ep debat
ep view take center stage recal back provid initi
ep guidanc somewhat disappoint rel investor
expect time compani proactiv provid comfort investor
also suggest preliminarili ep abl exceed sinc
ep perform better expect due part drug
oper also due tax reform despit tailwind session
barclay hc confer last month led us believ debat
whether cah ep still exceed sever headwind tailwind
debat see take-away note servic barclay care
confer day quick takeaway fact debat
point suggest ep could well street current view
lower ep buy-sid sell-sid drug price risk one key
point discuss confer relat cah invest custom
relationship interpret mani way sens net result
risk addit headwind profit sens brand mfr
econom becom topic distributor well last time brand mfr
econom topic mid-calendar three distributor seem
issu net reduct profit convert brand mfr new
first-tim fee-for-servic ff contract valeant convers big factor
back also like lose pharmerica custom sever
manufactur cost headwind cite medic side well combin
debat point takeaway industri quarterli preview
servic channel check leav ep
estim unchang trim ep
growth schedul report earn may barclay street
expect updat earn outlook lower ep growth
next year trim pt price-to-earnings lower calendar
ep
quarterli annual ep usd
consensu number thomson reuter
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
lower usd
return equiti ttm
link barclay live interact chart
equal weight equal weight
compani continu see gener price deflat
issu within cordi busi point
larg price stock see rel
minim upsid downsid
upsid case gener price
improv modestli lead multipl expans
ep
downsid case see gener price continu
remain heavili deflationari improv
seen cordi busi lead price
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
author contribut research report research analyst unless otherwis indic
public date top report reflect local time report produc may differ releas date provid
gmt
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis barclay research depart
oper independ absa research depart absa research produc absa bank limit act corpor
invest bank divis part barclay africa group limit affili invest bank barclay bank plc elig
client may receiv research report research depart may reach differ conclus may contain differ
conflict forecast recommend trade idea
price sourc thomson reuter last avail close price relev trade market unless anoth time sourc
